Equine CA50 antibody and antigen (recombinant protein)

Diagnostic anti-Equine CA50 antibodies pairs and antigen for animal health (animal Equine/Horse pancreatic and colorectal cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-CA50-Ag01Equine CA50$3090.00
GMP-EQU-CA50-Ab01Anti-Equine CA50 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CA50-Ab02Anti-Equine CA50 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CA50-Ab03Anti-Equine CA50 human monoclonal antibody (mAb)$3090.00
GMP-EQU-CA50-Ab04Anti-Equine CA50 human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-CA50-Ag01
Product NameEquine CA50
Target/BiomarkerEquine CA50
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine CA50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA50 level test of animal Equine/Horse with pancreatic and colorectal cancer.
TagHis
Reconized/Reactive SpecicsEquine CA50
Product descriptionRecombinant Equine CA50 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CA50-Ab01,GMP-EQU-CA50-Ab02
Target/BiomarkerEquine CA50
Product NameAnti-Equine CA50 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine CA50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA50 antibodies in Equine CA50 level test of animal Equine/Horse with pancreatic and colorectal cancer.
Product descriptionAnti-Equine CA50 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA50 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CA50-Ab03,GMP-EQU-CA50-Ab04
Target/BiomarkerEquine CA50
Product NameAnti-Equine CA50 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine CA50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA50 antibodies in Equine CA50 level test of animal Equine/Horse with pancreatic and colorectal cancer.
Product descriptionAnti-Equine CA50 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Carbohydrate Antigen 50 (CA50) is a glycoprotein biomarker with vital implications in equine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in horses, with a significant focus on those affecting the gastrointestinal and pancreatic regions. Structurally, CA50 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules.

    In the context of equine health, elevated levels of CA50 in a horse's bloodstream can serve as a crucial indicator of the presence of specific cancers. The production and release of CA50 by cancer cells, especially those found in gastrointestinal and pancreatic cancers, lead to increased concentrations of this glycoprotein in the blood.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.